Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.

The reduced likelihood of initiating a DMT in patients with IHD or anxiety was consistent across age groups, although with the smaller sample sizes, most findings did not reach statistical significance (figures e-1 to e-4).

also in 111,027 other papers